Effect of intravitreal triamcinolone in advanced coats disease
Purpose: : To report our experience with intravitreal triamcinolone (IVTA) in cases of advanced Coats disease with massive subretinal exudation (MSRE) Methods: : Two eyes of two cases of advanced Coats disease, one eye with stage 4 disease and one with stage 5, received IVTA. One eye received 1mg an...
Saved in:
| Main Author: | Ghazi, Nicola G. (author) |
|---|---|
| Other Authors: | Al Shamsi, Hanan (author), Larsson, Jorgen (author) |
| Format: | article |
| Published: |
2011
|
| Online Access: | http://hdl.handle.net/10725/10877 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://iovs.arvojournals.org/article.aspx?articleid=2361970 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravitreal triamcinolone in coats' disease
by: Ghazi, Nicola G.
Published: (2012) -
Intravitreal bevacizumab (Avastin) treatment of retinal angiomatous proliferation
by: Ghazi, Nicola G.
Published: (2008) -
Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration?
by: Ghazi, Nicola G.
Published: (2010) -
Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion
by: Ghazi, Nicola
Published: (2003) -
Intravitreal adalimumab in active noninfectious uveitis
by: Hamam, Rola N.
Published: (2016)